Lockheed Martin says PAC-3 MSE shipboard tests are planned for 2028 with fielding aimed for 2029
Lockheed Martin (LMT) plans to test its PAC-3 MSE interceptor for the U.S. Navy in 2028, with deployment targeted for 2029. The company invested $120M in development, following a $93M contract. Recent tests showed successful integration with Mk 41 launchers and Aegis systems. Lockheed is modifying hardware and software for naval use, aiming to meet evolving threats. Production will occur at its Camden, Arkansas facility.
How this was made
The 30-second read
Why it matters
The disclosed contracts represent a major revenue boost and may drive the stock higher ahead of upcoming earnings.
Market read
First‑report contract award of significant scale, likely to influence Lockheed's stock and the broader defense sector.
What to watch
Potential cost overruns in hardware/software development and competition from other missile manufacturers.
Background
Lockheed Martin is expanding its PAC‑3 MSE program for both Navy and Army, integrating new launch hardware and software.
Ticker impact
Lockheed Martin announced a $93 million Navy contract and a $58 billion Army contract to produce PAC‑3 MSE interceptors, marking the first public disclosure of these deals.
upward pressure as the market prices in the large contract wins
Multi‑billion‑dollar Army award and new Navy program of record are material to earnings and cash flow, likely prompting buying interest.
Market effects
Boosts outlook for defense and missile‑system suppliers, may lift peers in the aerospace & defense sector.
Positive for U.S. defense contractors and related supply chain firms.
Reinforces confidence in U.S. defense spending, modestly affecting global defense equities.
Counterpoint
If the contracts face integration delays or budget cuts, the upside could be limited.
Key entities
- CompanyLockheed Martin
U.S. defense contractor receiving major Navy and Army contracts.



